1. A new antibiotic selectively kills Gram-negative pathogens
- Author
-
Imai, Yu, Meyer, Kirsten J., Iinishi, Akira, Favre-Godal, Quentin, Green, Robert, Manuse, Sylvie, and Caboni, Mariaelena
- Subjects
Nematoda -- Physiological aspects ,Microbiota (Symbiotic organisms) -- Physiological aspects ,Drug resistance in microorganisms -- Physiological aspects ,Drug discovery -- Methods ,Gram-negative bacteria -- Physiological aspects ,Antibiotics -- Properties ,Environmental issues ,Science and technology ,Zoology and wildlife conservation - Abstract
The current need for novel antibiotics is especially acute for drug-resistant Gram-negative pathogens.sup.1,2. These microorganisms have a highly restrictive permeability barrier, which limits the penetration of most compounds.sup.3,4. As a result, the last class of antibiotics that acted against Gram-negative bacteria was developed in the 1960s.sup.2. We reason that useful compounds can be found in bacteria that share similar requirements for antibiotics with humans, and focus on Photorhabdus symbionts of entomopathogenic nematode microbiomes. Here we report a new antibiotic that we name darobactin, which was obtained using a screen of Photorhabdus isolates. Darobactin is coded by a silent operon with little production under laboratory conditions, and is ribosomally synthesized. Darobactin has an unusual structure with two fused rings that form post-translationally. The compound is active against important Gram-negative pathogens both in vitro and in animal models of infection. Mutants that are resistant to darobactin map to BamA, an essential chaperone and translocator that folds outer membrane proteins. Our study suggests that bacterial symbionts of animals contain antibiotics that are particularly suitable for development into therapeutics. Bacterial symbionts of animals may contain antibiotics that are particularly suitable for development into therapeutics; one such compound, darobactin, is active against important Gram-negative pathogens both in vitro and in animal models of infection., Author(s): Yu Imai [sup.1] , Kirsten J. Meyer [sup.1] , Akira Iinishi [sup.1] , Quentin Favre-Godal [sup.1] , Robert Green [sup.1] , Sylvie Manuse [sup.1] , Mariaelena Caboni [sup.1] , [...]
- Published
- 2019
- Full Text
- View/download PDF